Alzheimer’s Disease Study
This clinical trial is designed to investigate a new treatment aimed at slowing cognitive decline in individuals diagnosed with Alzheimer's disease. The study will evaluate the therapy's impact on memory, thinking skills, and daily living activities.
ELIGIBILITY CRITERIA
We are looking for participants who meet the following criteria:
- Diagnosed with mild to moderate Alzheimer’s disease.
- Experiencing noticeable memory loss and cognitive difficulties.
Study Details
Participants will receive the investigational medication and undergo regular cognitive assessments, brain imaging, and laboratory tests to monitor the treatment’s effects. The study aims to determine if the therapy can slow the progression of Alzheimer’s symptoms and improve quality of life.
As part of this paid clinical trial, participants will be compensated for their participation, offering an opportunity to contribute to advancing Alzheimer’s research while earning money.
Do you meet the criteria and want to join the study?
If your child meets the criteria and you are interested in contributing to this important research, they may qualify for this study. For more information or to discuss eligibility, please contact the Haltha team at Haltha Connect.
Take part in live studyUnlock Exclusive Content by Subscribing to Our Updates
Stay informed about the latest advancements, breakthroughs, and trends in medical research
